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Am o n (]' se veral m onocl onal antibodies (mo ABs) directed 
agains~huma n interleukin 2 ([L-2), the 15-2 moAB raised 
in o ur labo ratory aga inst un g lycosylatcd reco mbinant IL-
2 (pro du ced in Escherichia co li) cross-reacted with a hum an 
skin epitope. Th1s moAB gave a strong stammg on the 
cell-surface m embranes of keratinocytes from the g ranular 
layer of the epidermis. In addition, the 15-2 m o AB stained 
15 o/o of epid ermal cell suspensiOns obtamed from suction 
b lis te rs and reacted with cells fro m the spinous layer in 
par ak eratos is and psorias is , as well as with spin ous epithe-
lio m a cells. Prein cubation of the 15-2 m oAB with pure 
h un1 an recombinant fL-2 abroga ted skin binding, whereas 
M onoclonal antibod ies (m o ABs) arc pow erful re-agents fo r di agnos ti c and histo logic analysis of fi:ozen tissue sections. In addition, they have raised new ques tions abo ut cell lineage in cases when a m o AB raised against a specifi c anti gen (fo r 
ins t an ce, a th ymocy te fo r the O KT6 m o AB) cross-reacts w ith 
oth er stru ctures (s uch as Langerh ans cell s) [1 ,2]. 
T hi s "cross-reacti ve" sta ining, w hi ch has been noted in man y 
o the r instances, m ay indicate th e presen ce o f similar anti gens, 
su gges tin g embryo logic communities of th e stained cells [3] o r a 
cross-reacti ve cpito pe such as suga r m oieties [4J. Thts paper re-
ports such an e xa mple in which a m o AB raised aga inst recom-
bi n an t (Esrhcnclua co lt ); un glycosy latcd mterleukm 2 (riL-2) re-
cogni zed a cross-reactive cpi tope on cpiderm:1l cells of the g ran-
ula r laye r of human skin . This epi tope (no t recogni zed by 2 o th er 
an t i-!L-2 m o AB s) w as also fo und in epidermal cell suspensions. 
MAT ERIALS AND METH O D S 
Skin Specimens Fifteen no rmal cutaneo us sa mples were stud-
ied . In addi tion, bio psies o f various cutaneous les ions w ere ana-
lyzed : 5 untrea ted pso ri as is, 5 parakeratos is, 5 basal cell epithe-
lio m a, and 5 w ell-differentiated spinous cell epithelio ma. Finall y, 
15- 2 m o AB was also studi ed on no rm al rabbit epidermis. 
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a polyclonal antikeratin antiserum did no t block 15-2 skin 
bindin g. Two o ther anti-lL-2 moABs, one directed aga inst 
unglycosy lated recombinant IL-2 (17-2 moAB) and one 
against glycos ylated natural lL-2 (9B 11 IE5 moAB), were 
unreacti ve on skin . T aken together , the data sugges t th at 
the 15-2 moAB binds to an epitope cross-reacting with , 
but different fro m, IL-2 whi ch is loca ted in the cell-surface 
membranes of g ranul ar la yer cell s. This cross-reactive ep-
ito pe may provide a useful probe fo r the stud y of human 
epiderm al cell differentiati on.) !nt;cst D cml(lfo/ 86:359- 362, 
1986 
Epidermis Cell Suspensions E pidermi s cell suspensions w ere 
prepared from blister roof obtained accordin g to Kii stala's suction 
blister meth od [5]. The blister roofs were cut into sm all pieces 
and in cubated 1 h at 37°C in phos phate-buffered sa line (PBS) 
containing 0.02% EDTA and 0.05% trypsin (Cat . no . 0152-1 3, 
Difco, Michiga n). Cells w ere detached by min cing the roo£~ be-
tween 2 sca lpels. The cell suspensions thus o btained w ere w as hed 
extensivel y with Dulbccco 's minimal Eagle's medium (Gibco, 
Sco tland) con taining 10% (v/ v) fetal calf serum and incubated 
overni ght at 37°C befo re usc in la beling experim ents. 
Interleukin 2 Recombinant IL-2 (riL-2) was o btained from the 
Biogcnc Company (Geneva , Switzerland ). The riL-2 w as pure 
(1 band on sodium dodecyl sul fa te-page analysis and 1 spo t on 
bidimensional electropho resis [6]). T he unit of riL-2 used in the 
paper was ca lculated usin g the IL-2 g rowth-dependent C TL-L2 
murine cell line as previously indi ca ted [7]. O ne o f our loca l units 
co rresponds to 150 BRM P (Bio logica l Response M odifiers Pro-
g ram of the N ational Cancer Institute) units. 
Monoclonal Antibodies The 15-2 and 17-2 moABs were raised 
aga inst IL-2 (produ ced by E. coli) after immuniza ti on ofB ALB/ c 
mi ce and cell fu sion of splenocy tes w ith m ouse 5p 20 14myelom a 
ccUs. These 2 immun og lobulins arc o f the same IgG2,. subcl ass, 
as described in detail elsewhere [SJ. C haracterization of these moABs 
w as based on the inhibition of pro liferati on of an IL-2-dcpendent 
mouse T-cellline (CTL-L2) w ith va rio us kin ds o fiL-2, on affi nity 
chro m atograph y assays and immunoprccipitation of radio labeled 
lL-2; 15-2 and 17-2 w ere also fo und to recognize different epitopes 
on th e un glycosylated IL-2 m olecul e [8]. An o ther moAB (9B11 
IE5) used in this stud y was raised aga inst natural JL-2 produced 
by a human leukemi a T-cellline jurkatt [9]. This mo AB, kind ly 
pro vided by J. R. Hobb (Dupont, G leno lden Laborato ry, Glen-
olden, Pennsylvania), is di rected aga inst th e Nl-1 2 termin al g ly-
cosylarcd group of the IL-2 m olecule. 
Indirect ln1munoftuorescence on Epidennal Cell Suspen-
sions and Tissue Sections T he reactivity o f an ti-IL-2 m oABs 
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Figure 1. 15-2 111 o AB l:lbe ling of the g ranular laye r in no rm al hum :tn 
skin ( x 300). 
was stud ied on ep iderm al cell sm ea rs obtaim:d fro m epiderm al 
suspensions and on no rm al and lesional sk in w hi ch was snap-
frozen in liquid nitrogen, maintained at - 80°C and cut w ith a 
cryos tat into 4-J.Lm sections. These smea rs and sections were im-
mersed for 10 min in acetone and was hed in PBS. T he anti-IL-2 
moABs we re used at 4 p.g/ rnl ( l :50). After 30-min incubat ion at 
37°C, the secti ons were washed in PBS, and flu o rescein-conju-
ga ted goa t anti mouse lgG (Meloy), diluted 1: 5 was applied for 
a furth er 30 min at 37°C. After an add itio nal washin g in PBS the 
sa mples were mounted usin g buffered g lyce rin . 
The secti ons we re exa mined at X 300 and X 500 magnifi cations 
with a Ze iss UV mi croscope. The percen tage of keratin o-
cytcs was determin ed by doubl e labeling to eliminate Langcrhans 
cells, mclanocy tes, and fibro blasts. T he sections were first in-
cubated with a po lykeratin antiserum (1 : I Tebu), and rh odamine-
conju ga ted goa t antimouse lgG, diluted I :3, was appli ed. T hen 
15-2 was applied and revea led with flu oresce in-conju gated goat 
antimouse lgG (Meloy) d ilu ted I :5. O ne hundred consecuti ve 
cells were counted in 5 smears, and the percenta ge of cells dis-
a 
d 
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Figure 2. T he 15-2 m oAB la beling of g ranular layer ce ll s is res tricted to 
cdl sur f:occ mcmbr:tnc (X 500). 
pl ay in g g reen flu orescence was determined among red labeled 
cell s. Control secti ons, using either no rmal unJabelcd mouse serum 
or fluorescein-conjuga ted goa t ant imouse lgG alone, were simi-
larl y processed and found negative in all cases. 
IL-2 Blocking of 15-2 Skin Staining In some ex perim ents, 
th e 15-2 mo AB was preincubatcd w ith IL-2 before being used on 
skin. Two concentration s of pure IL-2 ('10, 101 , and 10.1 units) 
we re used at 37°C for 15 min . The mi xture was th en used for 
immunolabelin g of frozen tissue sections as prev iously des ribed . 
HES ULTS 
Staining of Cutaneous Sections Fig 1 shows th e stainin g ob-
tai ned when 15-2 m o AB was used on no rm al human skin. Sta ined 
cel ls we re fo un d onl y in the g ranular la yer of the epidermis. T his 
labelin g was res tri cted to cell-sur face m embrane (Fig 2); no la-
beli ng was seen in the basa l, sp inous, and stratum corn eum b yers. 
G ranul ar laye r sta inin g was spcc ies-specif1 c since no m o AB reac-
tivit y w:~s noted on no rm al r :~ bbit sk in . In contrast, the 17-2 
mo AB w hi ch is on immunoglobulin of the same species and 
subcla ss (lgG1,) as the 15-2 m o.AB but recogni zin g another epi-
tope of the IL-2 molecule, gave no stainin g (Fig 3e). 
An other moAB (9B11 l£5) directed aga inst human g lycosy-
lated IL-2 was also studied on the sa me skin sections and displayed 
no s t :~ inin g (Fig 3f). In o rder to confirm the cross-reactivi ty of 
an ep itope shared by th e g ranular laye r of human skin and IL-2 
molecules, and to rule out the poss ibility of there being 2 d ifferent 
b c 
e f 
Figure J. 11~c, Block ing of 15-2 m o AB sk in stai ni ng by preincubation of 15-2 w ith pure r iL-2. There is an ab rogation of 15-2 stainin g o n the g ranular 
layer w ho ch os dose dependent. d, Contro l sccro on wtth o nl y ftu o resccin-labclcd second ant1body (goat anti mo use lgG). e tmd .f, N o staining of g ranu lar 
layer w oth 2 other anto- IL-2 m o ABs: 9B 11 1ES mo AB directed aga inst g ly ·osy la tcd 1L-2; 17-2 m o AB w hi ch is a mo AB of the sa me subclass as 15-_ 
mo AB but recognizin g ano ther cpito pc. x 500. 
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Figure 4. 15-2 bbclin g o f epiderm al ce ll _ suspensio ns. Cell s labe lc~-l b y_ 
the m o n o clo nal ann- IL-2 show bn g ht sramm g. They represent 15 Yo o t 
the cell s s ta ined b y a po lycl onal anrikeratin amibod y. X 300. 
antibo dies in the 15-2 preparatio n, cross-competition contro ls 
wer e set up. In th ese experim ents, as indi cated in 111/ateria/s a11d 
Methods, th e 15-2 mo AB w as prein cubated with pure IL-2 at 
vario us concentrations before skin staining. Fig 3a-c indica tes that 
this procedure could c_o mplete ly and in a dose-de pendent manner 
abrog ate 15-2 reactiVIty aga mst th e g ranular layer, confirmmg 
the thesis of the cross-reactive ep!to pe. 
The residua l staining o bserved after preincubation w ith IL-2 
was comparable to th e contro l stain in g observed in th e absence 
o f 15-2 (fluorescein-la beled second antibody) alone (Fig 3d). This 
residual stainin g was nonspecifi c :md very li kely corres pond ed to 
ab sorpti o n of fluoro chrome on the stratum corneum laye r. 
Staining of Epidermal Cell Suspensions Ninety-five percent 
of the cells were sta ined by polyclonal se ra directed aga inst ker-
atin. Am ong these keratin-positive cell s, 15 ::':: 3% (Fig 4) were 
also stained by th e 15-2 moAB. N o inhibition o f 15-2 mo AB 
sta inin g occurred w hen th e epiderm al cell s were trea ted by poly-
clonal antikeratin serum before addm g the 15-2 mo AB, wh1ch 
sugges ts that the latter antibody was no t directed aga inst an ep-
ito p e present on keratms. 
15-2 Staining of Pathologic Skin Sin ce abn orm ali tes o f the 
g ranu lar layer have been found in pso riasis and parakeratosi s, skin 
sa mples of these 2 diseases were studied . F1g 5a,b s ho ws th at Jn 
bo th diseases , in which th e g ranular layer Js lackm g [1 0], 15-2 
sta inin g w as found on spin ous layer cell s. Aga in , basa l layer cell s 
we re not labeled . In additi on, basal and spinous epitheli o ma sec-
tion s were anJiyzed to determin e wheth er this cross-reactive ep-
itop e w as ex pressed on th ese can cer cel ls. Altho ugh no staining 
of b asa l epithelio ma cells was obse rved, al l spm ous ep!theho ma 
cell s were labeled by th e 15-2 moAB . 
D ISC U SS ION 
O ur s tudi es sho w th at an anti- r!L-2 moAB ca n be used as a marker 
of g r anu lar Ia yer cells o f human skin on frozen tiss ue sections 
and that 15% o f epiderm al cell s produ cing keratm 111 cellular 
sus p e nsion arc also stained by thi s antibody._ . _ 
O ther instances of moAB rai sed aga mst antigens , d1fterent fro m 
those of skin and display ing cross-binding on epiderm al struc-
wres, have alread y been repo rted 13, 11] . Among these, th e B L7 
moAB raised against th ymi c cells [1 21 binds on epiderm al basa l 
cell s ; th e BL9 moAB raised against th e n.aji cell line cross-reacts 
with th ymic epith elium and a membranous keratinosis anti ge n 
[12 ]; and th e 4F2 mo AB generated aga inst th e HSB2 human T -
cell line also binds to an ep1rope present on the skm basal laye r 
[13). - . 
T h e labeling o f the g ranul ar layer o t human skm by th e 15-2 
moAB is rel ated to idio typi c recognition o f an epito pe and not 
ro un specifi c binding as stainin g could be abcoga ted w hen th e 
antibo dy was prein cubated with pure r!L-2 befo re reactin g on the 
skin . A lthough some epidt:rmal cell s have been shown ro produ ce 
IL - l [14] and IL-3 in rodents [1 5], it is very unlikely that the 15-
2 m o AB binds to a putati ve IL-2-Iike molecule present at th e 
surface of granular laye r cell s since o ther mo ABs also directed 
against JL-2 g:1 ve no staining . As th e 15-2 mo AB is directed 
agains t un glycosylated IL-2 produ ced in E. co li 18], the cross-
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Figure 5. n, Sp in o us la ye r ce lls labe led by 15-2 m o A B in pso ri as is. In 
thi s spec imen , the spin o us la ye r ce ll s ar-c labeled by th e mo AB ( X 300) . 
b, At hi gher m agni fica tio n rhe sta in ing is res tri crcd ro th e cell surface 
m embrane ( X 500). 
reactive epi to pe is no t a sugar. Furtherm o re, the 9B 1·1 IE5 m o AB 
w hi ch has been rJ ised aga inst " natural" IL-2 and which recogni zes 
g lycosy lated stru ctures on the third NI-1 2 termin al amino acid of 
IL-2 [91, was un able ro bind g ranular cell s. In addition, 17-2 
mo AB, th :H like 15-2 was raised in our laboratory agJ inst r!L-2 
but directed aga inst a di fferent cpitope on the r!L-2 molecul e [8], 
was also unable to bind on th e g r:1nular layer, w hi ch indica tes 
th at the cross-reacti vity described was res tri cted to a peculi ar anti-
IL-2 mo AB instead of in vo lving all o f them . Finall y, as polyclonal 
antikeratin antibodies coul d no t abroga te 15-2 staining on skin , 
it is unlikely that keratin bea rs th e cross-reactive epito pe. O nly 
studi es using immunoprecipitati on w ill allow further biochemica l 
inform ati on about th e cross-reactive anti gen present on g ranul ar 
laye r cell s. Howeve r, taken together, our data strongly suggest 
that 15-2 recogni zes a cross-I-cJcti ve epitope w hi ch is in the skin , 
not loca ted on an IL-2 molecule . 
O ur studies also show that in pso ri Js is and para keratos is, in 
which th e g ranu lar layer is la ckin g, the 15-2 mo AB was able to 
label rh e spinous la yer, w hich was no t stained in no rm al skin . 
Thus, the 15-2 mo AB , along w ith antibodi es directed aga inst 
cy tokeratin [I Gl or g lyco pro teins present on d ifferent epiderm al 
la ye rs [ 17], appea rs to be an o ther useful nu rk er of a difte rentiati on 
step fo r the g rJnul ar layer (i.e. , mature cell s), the ex pression of 
w hi ch is modifi ed in cutaneous les ions w ith keratini za ti on ab-
norm alities and remains present on spinous epithelioma cells. 
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